Skip to main content

Find Clinical Trials

Home
Conditions
Metastases, Neoplasm

Clinical trial condition

Metastases, Neoplasm

Explore clinical trials studying Metastases, Neoplasm. Study availability and eligibility vary by location and protocol.

18 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Metastases, Neoplasm trial results

Recruiting

Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas

NCT05419518

Conditions: Bone Diseases, Bone Neoplasms, Metastases, Neoplasm, +8 more
Locations: RWJBarnabas Health - Robert Wood Johnson University Hospital Hamilton, New Jersey, United States

RWJBarnabas Health - Monmouth Medical Center Southern Campus Lakewood, New Jersey, United States

RWJBarnabas Health - Saint Barnabas Medical Center Livingston, New Jersey, United States

Robert Wood Johnson University Hospital New Brunswick, New Jersey, United States

View Trial Details

Completed

Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel

NCT00039780

Conditions: Breast Diseases, Breast Neoplasms, Chemically-Induced Disorders, +17 more
Locations: Not specified

View Trial Details

Completed

High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors

NCT00037869

Conditions: Metastases, Neoplasm, Neoplasm Metastasis, Neoplasms, +8 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Surgical Treatment of Pancreatic RCC Metastases

NCT03670992

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
Locations: Department of Surgery "Pietro Valdoni" Roma, Italy

View Trial Details

Completed

Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases

NCT02265549

Conditions: Metastases, Neoplasm, Neoplasm Metastasis, Neoplasms, +3 more
Locations: Maastro Clinic Maastricht, Netherlands

View Trial Details

Completed

ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer

NCT00046514

Conditions: Breast Diseases, Breast Neoplasms, Metastases, Neoplasm, +8 more
Locations: Abraxis BioScience, Inc. Raleigh, North Carolina, United States

View Trial Details

Completed

A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies

NCT00046423

Conditions: Metastases, Neoplasm, Neoplasm Metastasis, Neoplasms, +3 more
Locations: Abraxis Bioscience, Inc. Durham, North Carolina, United States

View Trial Details

Completed

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer

NCT00034918

Conditions: Breast Diseases, Breast Neoplasms, Metastases, Neoplasm, +8 more
Locations: Research Site Indianapolis, Indiana, United States

Research Site Barcelona, Spain

View Trial Details

Completed

A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer

NCT00055471

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations: Research Site Cleveland, Ohio, United States

Research Site Madison, Wisconsin, United States

View Trial Details

Completed

Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients

NCT00037609

Conditions: Breast Diseases, Breast Neoplasms, Metastases, Neoplasm, +8 more
Locations: University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details